Toth Financial Advisory’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,000
Closed -$48.7K 737
2023
Q4
$48.7K Hold
2,000
0.01% 301
2023
Q3
$44.8K Hold
2,000
0.01% 286
2023
Q2
$51.2K Hold
2,000
0.01% 268
2023
Q1
$47.3K Hold
2,000
0.01% 280
2022
Q4
$43.6K Hold
2,000
0.01% 290
2022
Q3
$49K Hold
2,000
0.01% 275
2022
Q2
$54K Hold
2,000
0.01% 261
2022
Q1
$78K Hold
2,000
0.01% 248
2021
Q4
$92K Hold
2,000
0.01% 241
2021
Q3
$95K Hold
2,000
0.01% 246
2021
Q2
$93K Hold
2,000
0.01% 225
2021
Q1
$88K Hold
2,000
0.01% 239
2020
Q4
$82K Hold
2,000
0.01% 227
2020
Q3
$75K Buy
+2,000
New +$73.7K 0.01% 220

Other funds holding FFTY

Toth Financial Advisory's FFTY Position: Q1 2024 in Review

Toth Financial Advisory sold out of CapForce IBD 50 ETF (FFTY) in Q1 2024, closing a stake of 2,000 shares — an estimated $48.7K sold.

Toth Financial Advisory first reported a position in FFTY in Q3 2020 and held it in 14 quarters. The position peaked at $95K in Q3 2021. 40 funds tracked by Wall St. Rank hold FFTY as of Q1 2024.

  • Toth Financial Advisory reported no remaining CapForce IBD 50 ETF position as of Q1 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 2,000 CapForce IBD 50 ETF shares in Q1 2024, an estimated $48.7K.
  • Toth Financial Advisory first reported a position in CapForce IBD 50 ETF in Q3 2020 and held it in 14 quarters.
  • Toth Financial Advisory's CapForce IBD 50 ETF position peaked at $95K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2024.

Based on Toth Financial Advisory's 13F filing for Q1 2024, filed 16 Apr 2024.